Valuation : RBC Bioscience Corporation

Market Cap 314M 9.93M 8.54M 8.04M 7.34M 13.73M 937M 13.77M 94.96M 36.85M 481M 37.27M 36.46M 1.55B P/E 2024
11.6x
P/E 2025 10.3x
Enterprise Value 669M 21.14M 18.19M 17.11M 15.63M 29.24M 2B 29.32M 202M 78.47M 1.02B 79.37M 77.64M 3.3B EV / Sales 2024
3.03x
EV / Sales 2025 2.71x
Free-Float
71.49%
Yield 2024
2.93%
Yield 2025 8.9%
1 day+3.04%
1 week-8.90%
Current month-9.28%
1 month+15.79%
3 months+15.18%
6 months+35.80%
Current year+30.56%
1 week 21.2
Extreme 21.2
28.15
1 month 18.5
Extreme 18.5
28.15
Current year 14.3
Extreme 14.3
28.15
1 year 14.3
Extreme 14.3
28.15
3 years 12.32
Extreme 12.318181
28.15
5 years 12.23
Extreme 12.227272
50.91
10 years 12.23
Extreme 12.227272
50.91
Manager TitleAgeSince
Chief Executive Officer - 2006-05-28
Director of Finance/CFO - 2016-08-31
Chief Tech/Sci/R&D Officer - 2022-12-22
Director TitleAgeSince
Chairman - 2006-09-14
Director/Board Member - -
Director/Board Member - 2021-09-15
Change 5-day change 1-year change 3-year change Capi.($)
+3.04%-8.90%+22.91%+69.23% 9.6M
-0.42%-3.68%-18.43%+5.33% 188B
+1.15%+3.22%+1.42%+14.66% 119B
-1.86%+2.77%+13.07%+89.16% 64.35B
-1.31%-1.09%+22.44%+46.84% 52.59B
-1.54%-2.52%-3.41%-33.66% 51.11B
-2.02%-3.22%+8.84%-13.73% 33.85B
0.00%+3.71% - - 32.1B
-0.81%+0.74%+37.34%-16.61% 24.12B
-1.44%-4.21%-7.37%+11.97% 23.39B
Average -0.52%-0.82%+8.53%+19.24% 58.89B
Weighted average by Cap. -0.56%+0.13%-0.76%+15.53%

Financials

2024 2025
Net sales 205M 6.49M 5.58M 5.25M 4.8M 8.98M 613M 9M 62.06M 24.08M 314M 24.36M 23.83M 1.01B 220M 6.94M 5.98M 5.62M 5.14M 9.61M 656M 9.63M 66.44M 25.78M 336M 26.08M 25.51M 1.08B
Net income 21.57M 682K 587K 552K 504K 943K 64.36M 946K 6.52M 2.53M 33.02M 2.56M 2.5M 106M 23.54M 744K 640K 602K 550K 1.03M 70.26M 1.03M 7.12M 2.76M 36.05M 2.79M 2.73M 116M
Net Debt 375M 11.85M 10.2M 9.59M 8.76M 16.39M 1.12B 16.44M 113M 43.98M 574M 44.49M 43.52M 1.85B 355M 11.21M 9.65M 9.08M 8.29M 15.51M 1.06B 15.55M 107M 41.62M 543M 42.1M 41.18M 1.75B
Logo RBC Bioscience Corporation
RBC Bioscience Corp is a Taiwan-based medical device manufacturer that provides manufacture and sale services for nucleic acid purification automation equipment and nucleic acid purification reagents. The company's products are mainly divided into instruments and reagents. The instruments are equipped with ultraviolet sterilization system to improve the quality of nucleic acid purification, and the disposable individual reagent strips and tips can be used with different built-in control programs to achieve different types of nucleic acid extraction. The company developed and produced a variety of nucleic acid purification reagents with cellulose-embedded magnetic beads, which can improve the purity of nucleic acid, and therefore can be used to purify deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) for blood, bacteria, viruses and forensic examinations for future diagnosis, prevention, tracking, treatment of diseases or identification.
Employees
50
Date Price Change Volume
26-09-04 NT$22.00 +3.04% 31,140
26-09-03 NT$21.35 -11.04% 149,765
26-09-02 NT$24.00 -11.11% 182,691
26-09-01 NT$27.00 +11.34% 437,405
26-08-31 NT$24.25 +0.41% 153,576
  1. Stock Market
  2. Stocks
  3. 6848 Stock